Local ablation in pancreatic cancer: some answers and more questions

Affiliations

¹ Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
² Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA. Electronic address: rewhite@health.ucsd.edu.

Comment

Zachary T Berman et al. Lancet Gastroenterol Hepatol. 2024 May.

. 2024 May;9(5):398-400.

doi: 10.1016/S2468-1253(24)00046-3. Epub 2024 Mar 19.

¹ Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
² Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA. Electronic address: rewhite@health.ucsd.edu.

No abstract available

Conflict of interest statement

RRW is a site Principal Investigator for the DIRECT Registry Study of NanoKnife IRE (NCT03899649). ZTB declares no competing interests.

MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial.
Timmer FEF, Geboers B, Ruarus AH, Vroomen LGPH, Schouten EAC, van der Lei S, Vos DJW, Dijkstra M, Schulz HH, Bakker J, van den Bemd BAT, van den Tol PM, Puijk RS, Lissenberg-Witte BI, de Gruijl TD, de Vries JJJ, Lagerwaard FJ, Scheffer HJ, Bruynzeel AME, Meijerink MR. Timmer FEF, et al. Lancet Gastroenterol Hepatol. 2024 May;9(5):448-459. doi: 10.1016/S2468-1253(24)00017-7. Epub 2024 Mar 19. Lancet Gastroenterol Hepatol. 2024. PMID: 38513683 Clinical Trial.